Central and peripheral nervous system effects of chronic renal failure  by Mahoney, Cynthia A. et al.
Kidney International, Vol. 24 (1983), PP. /70—177
Central and peripheral nervous system effects of
chronic renal failure
CYNTHIA A. MAHONEY and ALLEN I. ARIEFF
with the technical assistance of
WILLIAM J. LEACH and VIRGINIA C. LAZAROWITZ
The Division of Nephrology, Department of Medicine, Veterans Administration Medical Center and University of California
School of Medicine, San Francisco, California
Central and peripheral nervous system effects of chronic renal failure.
Although neurologic dysfunction is a major cause of disability in
patients with chronic renal failure, there is little knowledge of the
underlying metabolic defect(s). We used a canine model to study the
effects of chronic renal failure (CRF: 4 months after l-/s nephrectomy,
GFR 11 2 mI/mm) on the composition and function of the nervous
system. We also studied the effect of acute renal failure (ARF: 3.5 days
after bilateral ureteral ligation) on peripheral nerve composition and
function. In dogs with CRF for 4 months intracellular pH of brain and
cerebro-spinal fluid (CSF) pH remained normal, despite metabolic
acidemia. Osmotic equilibrium of the brain with plasma and CSF (and
thus a normal water content) was maintained by almost equivalent
increases in brain of urea and idiogenic osmoles (25 mmoles/kg H20 and
23 to 26 mOsm/kg H20, respectively). Electrolyte concentration in
brain tissue water did not change significantly. Calcium content was
increased in cortical gray matter and hypothalamus of dogs with CRF,
but was normal in the six other regions measured. Functional changes
measured by the electroencephalogram were just as severe as those
previously seen in dogs with ARF. The motor nerve conduction
velocity (MNCV) was normal in dogs with ARF and did not change
after up to 6 months of CRF. Similarly, nerve calcium content was
decreased in dogs with ARF and remained low after 4 months of CRF.
Thus, CRF of 4 months duration produced marked alterations of central
nervous system function and composition. Increases in brain calcium
content and/or the appearance of idiogenic osmoles may be involved in
the pathogenesis of central nervous system dysfunction. In contrast to
the findings in brain, nerve calcium and sodium content fell acutely, and
calcium remained low after 4 months of renal failure. Despite these
compositional changes, nerve function, as measured by the MNCV,
was unaffected.
Effets de I'insuffisance rénale chronique sur le système nerveux central
et périphérique. Bien que le dysfonctionnement neurologique soit une
cause majeure d'invalidité chez des malades atteints d'insuffisance
rénale chronique, il n'y a que peu de données sur le(les) trouble(s)
métabolique(s) sous-jacent(s). Nous avons utilisé un modèle canin pour
étudier les effects de l'insuffisance rénale chronique (CRF: 4 mois apres
l-/8 néphrectomie, GFR II 2 mI/mm) sur Ia composition et le
fonctionnement du système nerveux. Nous avons également étudié
l'effet de l'insuffissance rénale aigfie (ARF: 3.5 jours après ligature
urétérale bilatérale sur Ia composition et Ia fonction du nerf périphéri-
que. Chez les chiens atteints de CRF depuis 4 mois, le pH intra-
cellulaire du cerveau et le pH de fluide cerebro-spinale (C5F) restèrent
normales. malgré l'acidemia metabolique. L'equilibre osmotique du
cerveau avec le plasma et le CSF (et donc un contenu normal d'eau)
était maintenu par des augmentations a peu prés equivalentes de l'urée
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et des osmoles idiogeniques dans le cerveau (25 mmoles/kg H20 et 23 a
26 mOsm/kg H20, respectivement). La concentration d'electrolytes
dans l'eau tissulaire cérebrale n'a pas change significativement. Le
contenu calcique était augmente dans Ia matière grise corticale et
I'hypothalamus de chiens atteints de CRF, mais était normal dans six
autres regions mesurées. Les modifications fonctionnelles mesurées par
l'électroencephalogrammes étaient aussi sévères que celles vues aupar-
avant chez les chiens en ARF. Le vélocité du compartement du nerf
motique (MNCV) était normal chez les chiens en ARF et ne changeait
pas aprés jusqu'à 6 mois de CRF. De facon identique, le contenu des
nerfs en calcium était diminué chez les chiens en ARF et restait bas
aprés 4 mois de CFR. Ainsi, CRF de 4 mois a entrainé des alterations
marquees du fonctionnement et de Ia composition du système nerveux
central. Des augmentations du contenu calcique du cerveau et/ou
l'apparition d'osmoles idiogeniques pourraient être impliquees dans la
pathogenie du dysfonctionnement de système nerveux central. Par
opposition avec les résultats dans le cerveau, le contenu en calcium et
en sodium des nerfs a chute de facon marquee, et le calcium est resté
bas après 4 mois d'insuffisance rénale. Malgré ces modifications de
composition, le fonctionnement nerveux, mesuré par MNCV n'était pas
affecté.
Among patients with chronic renal failure, the nervous sys-
tem is the barometer of general well-being. Despite impressive
modifications of both the duration and quality of life by dialysis
or renal transplantation, patients with renal failure continue to
manifest a variety of neurological disorders [1, 2]. The symptom
complex may include loss of recent memory and impaired
ability to concentrate with depression, delusion, and slurring of
speech. As renal failure progresses, these may intermittently
include abnormalities of gait, myoclonus, and asterixis. Symp-
toms may progress to include gradually increasing depression of
sensorium, with inability to perform routine mental tasks.
Although uncommon, with more advanced renal failure there
may be seizures and eventually coma. In addition to central
nervous system abnormalities, patients with chronic renal fail-
ure may also have abnormalities of peripheral nerve function.
Uremic neuropathy is a distal mixed polyneuropathy which is
probably present in a substantial percentage of patients with
endstage renal disease [3].
There have been numerous studies, both in patients and
laboratory animals, which have described various aspects of the
nervous system abnormalities associated with acute renal fail-
ure (ARF) [1—7]. In our laboratory, we have previously pub-
lished studies on the effects of ARF on brain water, electro-
lytes, intracellular pH, nerve function, and the electroenceph-
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alogram (EEG) [8—12]. However, the effects of ARF on the
peripheral nervous system, and of chronic renal failure (CRF)
on both central and peripheral nervous system function and
composition have not been well studied. Chronic renal failure is
often associated with metabolic acidemia. It has been suggested
that with systemic acidemia, intracellular acidosis may be
present [13]. In numerous reviews of the effects of uremia,
alterations in brain intracellular pH (pHi) have been proposed
as a possible mechanism for central nervous system dysfunc-
tion [12—14]. Many important intracellular enzymes have a pH
optimum. A change in brain pHi could affect brain energy
metabolism and thus lead to important functional consequences
[151. Despite these speculations, brain pHi in CRF has not been
evaluated.
Alterations of central nervous system function, as quantitat-
ed by EEG changes [16], have been associated previously with
increased cortical gray matter calcium content in both humans
[12, 17] and dogs [10] with ARF. Although several investigators
have reported increased brain calcium in patients with CRF
[17—19], others report a normal brain calcium [20]. The in-
creased levels of brain calcium have been reported when
cortical gray matter has been measured separately, rather than
"whole brain." The effects of CRF on calcium content in parts
of the brain other than cerebral cortical gray matter and
subcortical white matter are not known.
Although peripheral neuropathy is a well known complication
of long standing severe renal insufficiency, the effects of ARF
on peripheral nerve composition and function are controversial
[6, 12].
The present studies were designed to evaluate the effects of
acute and chronic renal failure on peripheral nervous system
and of CRF on the central nervous system of dogs. Central and
peripheral nervous system function were evaluated with the
EEG and measurements of motor nerve conduction velocity
(MNCV), respectively. Biochemical studies included measure-
ments of intracellular pH, regional calcium distribution in brain,
and water and electrolyte content in brain and peripheral nerve.
Results of previous studies on central nervous system function
and composition during ARF in the dog have been included in
some tables and figures for purposes of comparison.
Methods
Animal groups. Studies were carried out in a total of 71
mongrel dogs of both sexes, mean weight (±sD) of 19.2 1.2
kg. The animal groups were :(1) normal dogs (N = 21); (2) dogs
with ARF for 3.5 days (N = 10); (3) dogs who had previously
been subjected to parathyroidectomy and then given ARF for
3.5 days (N 6); (4) dogs with CRF for 16 days (N = 10); (5)
dogs with CRF for 4 months (N = 10); (6) dogs with CRF for 6
months (N = 5).
Preparation of animal groups. Acute renal failure was in-
duced by the technique of bilateral ureteral ligation [8] in group
1. Chronic renal failure was induced by producing a 1-%
nephrectomy by selective infarction of one kidney followed 1
week later by contralateral nephrectomy [211. Dogs were then
maintained for periods of 16 days to 6 months (groups 4 to 6).
Parathyroidectomy was performed as previously described [9].
Dogs with CRF were given Nephrodiet (Triumph Pet Indus-
tries, Inc., Hillburn, New York) 32 g/kg daily, as well as ad jib
water to drink. The diet provided 35 mg/kg of calcium and 58
mg/kg of phosphate per day.
Prior to sacrifice, dogs were anesthetized with sodium pento-
barbital, intubated and mechanically ventilated to maintain the
arterial Pco2 at about 35 mm Hg [11]. The skull was unroofed
and the brain removed as previously described [8]. In groups 1
and 5, intracellular pH was measured in skeletal muscle, liver,
and brain cerebral cortical gray matter and subcortical white
matter. For measurement of pHi the ureters were ligated and
the isotopes ('4C-labelled dimethadione and 3H-labelled inulin)
were injected both intravenously and into the cisternal cerebro
spinal fluid (CSF) 1 hr prior to sacrifice of the animal [22—24].
The pHi was measured in brain white and gray matter, liver
and skeletal muscle using the distribution of '4C-labelled DM0.
Complete analytical techniques have been published [22—24].
The brain and muscle extracellular space (ECS) was measured
with 3H-inulin; liver ECS with endogenous chloride.
The water content of both skeletal muscle and brain tissue
samples was determined by oven drying tissue samples at 105°C
for 24 hr [8, 24]. The tissue samples were then extracted in
0.75 M HNO3 for 24 hr, and the supernatant was used for the
determination of sodium, potassium, chloride, magnesium, and
calcium [8, 9]. The magnesium and calcium were determined by
atomic absorption spectrophotometry [9], sodium and potassi-
um by flame photometry and chloride by potentiometric titra-
tion [8]. Segments of femoral nerve were cleared of fibrous
tissue, frozen in liquid nitrogen, and pulverized to powder while
under liquid nitrogen. The pulverized nerve was oven dried at
105°C for 24 hr and extracted in 0.75 M HNO3, as described in
brain [8]. The content in nerve of water, sodium, potassium,
chloride, magnesium, and calcium were determined in a similar
manner to that in the brain, Brain osmolality was measured in
mixed brain which was frozen in liquid nitrogen and extracted
in boiling distilled water [25].
The MNCV was evaluated in the peroneal and tibial nerves,
using an electromyograph system (TECA TE4, TECA Corp.,
White Plains, New York), using methods which have previous-
ly been described [12]. For measurement of MNCV, dogs were
restrained in a harness for at least 30 mm in a room with
ambient temperature at 21°C.
Prior to performing the EEG, animals were sedated with
diazepam, 0.5 mg/kg i.v., paralyzed with 1 mg/kg succinyl
choline, then intubated and mechanically ventilated to maintain
a Pco2 of 35 mm Hg. At least 3 hr elapsed between the
administration of diazepam and the EEG recording. Manual and
auditory stimulation was used to maintain a state of alertness in
the dogs [10]. Electroencephalograms were done using an eight-
channel electroencephalograph (Beckman Accutrace, Beckman
Instruments, Inc., Fullerton, California) with subdermal needle
electrodes with a time constant of 0.16 sec and muscle filter set
at 30Hz. The EEG was analyzed by a computer which provided
direct readout of percent frequencies below 5 Hz, below 7 Hz,
and above 9 Hz, and the percent EEG power below 5 Hz. The
techniques have previously been described [10, 12, 17].
In control dogs and those with CRF for 4 months, GFR was
measured by exogenous creatinine clearance, using standard
techniques of priming and infusion [14].
Statistical analysis. Data are presented as mean SE.
Statistical comparisons were made by comparison of experi-
mental data to the appropriate control, using the Student's t test
for unpaired data.
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Table 1. Effects of chronic renal failure on plasma and CSF
Na K Cl Ca Mg Osm HCO3
pH
Pco2 P02
mm HgmEqiliter
Arterial blood
Control (N 9) 149 3.96 112 5.16 1.56 299 19.8 7.36 36 9!
Chronic renal failure (N = l0) 149 3.81 110 5.64 1.98 338 15.6 7.25 38 85
Cerebro-spinal fluid
Control (N = 9) 157 2.98 131 4.81 2.4! 304 19.6 7.32 4! 66
Chronic renal failure (N = 10)a 156 2.84 130 5.26 2.48 346 19.5 7.31 43 51
Calculations. Solute concentration in intracellular fluid
(ICF) was estimated from the following relationship, where x
represents the solute in question. The CSF concentration was
used as the extracellular fluid concentration for gray matter,
while plasma was used for white matter [8]. The percentage of
ECS and H20 are relative to tissue wet weight.
Tissue H20 = (%ECS/%H2O)[ECS1 + [1 —
(%ECS/%H2O)][ICF]
The group mean and variance of ICF values given are a
function of the individual results generated using the group
mean ECS in the equation, with individual values of x.
Results
In dogs with ARF for 3.5 days, plasma creatinine was 11.7
0.8 mg/dl (1.04 0.07 mM), and plasma urea nitrogen was 202
14 mg/dl (72 5 mM). In CRF of 4 months duration, plasma
creatinine was 6.8 1.5 mgldl (0.6 0.13 mM), and plasma urea
nitrogen was 90 13 mg/dl (32.1 4.6 mM). Control values for
creatinine and urea nitrogen were 0.07 0.001 m and 4.9
0.2 m, respectively. The GFR was 11 2 mI/mm (control = 51
8 mI/mm). The cerebrospinal fluid urea nitrogen was 89 12
mg/dl (31.8 4.2 mM) at 4 months of CRF (control = 5.8 0.8
mM). The plasma osmolality was 338 5 mOsm/kg (control =
299 1 mOsmlkg, P < 0.01). Concentrations in plasma of
sodium, potassium, and chloride were not different from control
values. In CSF, osmolality (346 5 mOsm/kg) was significantly
greater (P < 0.01) than control (304 3 mOsm/kg). Concentra-
tions in CSF of sodium, potassium, and chloride as well as the
pH, Pco2 and bicarbonate, were not different from control
(Table 1). Two thirds of the increase in osmolality of both CSF
and plasma was due to an increase in the concentration of urea.
Central nervous system studies
Effects on pHi. Systemic acidemia was present after 4 months
of CRF (arterial pH = 7.25), but pH in CSF was normal. The
values for intracellular pH are shown in Figure 1. The pHi was
normal in brain cortical gray matter and subcortical white
matter, as well as in liver and skeletal muscle. Thus, despite
protracted metabolic acidemia, pHi was normal in all four
tissues examined.
Effects on brain solutes and osmolarity. Brain electrolytes
Blood CSF White matter Gray matter Liver Muscle
Values represent those found in dogs with chronic renal failure for 4 months duration.
I0I
Fig. 1. The effects of 4 months of chronic
renal failure (CRF) on the intracellular pH
(pHi). In dogs with CRF, the arterial pH is
significantly below control values. However,
pHi is normal in brain white and gray matter,
liver and skeletal muscle (*P < 0.01; control
(El), N = 9; CRF (s), N = 8).
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Table 2. Fluid and electrolyte composition of brain tissue and intracellular fluid
Gray matter White matter
Calculated Calculated
Cerebral cortex H20 ECS Na K Cl Na K Cl H20 ECS Na K Cl Na K Cl
Osmolarity Urea — —_________
m0smlkg mmoleslkg % wet mmoles/kg mmoles/kg % wet mmoles/kg
1120 H20 weight tissue H20 ICF weight tissue H20 mmoles/kg ICF
Control(9)a 303 5.8 80.66 21.9 65 118 51 30 161 21 66.36 7.2 71 118 56 60 132 47
±5 ±0.6 ±0.46 ±2.4 ±2 ±4 ±2 ±1 ±5 ±1 ±0.50 ±2.3 ±2 ±2 ±3 ±2 ±2 ±3
CRF(10) 341b 31.lb 80.65 23.9 67 111 53 30 158 21 66.78 10.1 70 110 52 55 129 38b
±18 ±2.4 ±0.38 ±1.5 ±3 ±3 ±3 ±2 ±4 ±1 ±0.49 ±1.6 ±5 ±4 ±4 ±4 ±4 ±2
a The number of animals in each group is given in parentheses.
b The value is significantly different from control values, P < 0.05.
Table 3. Effect of chronic renal failure on idiogenic osmoles
-
Cerebral cortex Gray matter White matter(mixed brain) -_________________________________________
osmolarity (Urea + Na + K + Cl) Undetermined solute (Urea + Na + K + Cl) Undetermined solute
m0sm/kg 1120 mmoles/kg H20 mosm/kg H20 mmoleslkg H20 mosm/kg H20
Control (8)" 303 ± 5 253 ± 6 50 ± 3 258 ± 4 44 ± 5
CRF (5)" 350 ± 16 274 ± 10 76 ± l3c 283 ± IS 67 ± 8'
a Idiogenic osmoles are calculated as the difference between the increase in osmolarity and the increase of measured solute (urea + Na + K +
Cl): gray matter, 26; white matter, 23.
b The number of animals is given in parentheses.
The value is significantly different from the control value, P < 0.05.
were measured in white and gray matter of control dogs and
those with 4 months of chronic renal failure (Table 2).
Water content and ECS of cerebral cortical white and gray
matter were normal in chronic renal failure. Although potassi-
um concentration tended to be lower in CRF, there were no
significant differences in the concentrations of sodium, potassi-
um, or chloride in brain tissue water of CRF animals versus
control (Table 2). Brain osmolarity (341 ± 18) was similar to
that of CSF (346 ± 5 mOsm/kg H20) and plasma (338 ± 5
mOsm/kg H20) in CRF.
An estimate of brain intracellular fluid (ICF) composition was
calculated from the concentrations of solute in tissue water, the
water space (% H20), and the extracellular fluid space (% ECS)
as described in Methods. Calculated osmolarity and urea con-
centrations in ICF were identical to those of tissue water with
the exception of gray matter ICF osmolarity (339 mOsm/kg
ICF). Intracellular sodium and chloride were lower, while
potassium was higher than that measured in tissue water for
both control and CRF (Table 2). The effects of CRF on
estimated intracellular composition were similar to those seen
in tissue water. In both gray and white matter osmolarity
increased by about 40 mOsm/kg H20, of which 25 mOsm could
be attributed to urea. Idiogenic osmoles accounted for 14 to 29
mOsmlkg ICF in gray and white matter, respectively. In
addition, there was a slight decrease of the electrolyte concen-
tration in brain ICF of CRF animals, which was statistically
significant only for chloride in white matter (P < 0.05).
The contribution to the increased osmolarity made by unmea-
sured solutes was calculated in two groups of animals in which
osmolarity, urea, and electrolyte concentration (Na + K + Cl)
had all been measured on the same tissue samples (Table 3).
Brain osmolarity was 47 mOsm/kg H20 higher in dogs with
CRF than control animals, yet the sum of the measured solutes
(urea + Na + K + Cl) rose by only 21 mmoles/kg H20. The net
increase in measured solute was accounted for by an increase in
urea (27 mOsm/kg H20) and a slight fall in electrolyte concen-
tration. Unmeasured solute increased in gray matter from 50 ±
3 mOsm/kg H20 (control) to 76 ± 13 mOsm/kg H20 (CRF, P <
0.05) and in white matter from 44 ± 5 to 67 ± 8 mOsm/kg H20
(CRF, P < 0.05). Thus, the increase of unmeasured solute
(idiogenic osmoles: 23 to 26 mOsm/kg H20) contributed almost
as much to the increase of brain osmolarity as did urea.
Effects on brain calcium and magnesium. Calcium was
measured in dogs with CRF (4 months) in eight different areas
of the brain (Fig. 2). The calcium content was not different from
control values in the subcortical white matter, pons, medulla,
cerebellum, thalamus, and caudate nucleus. In both the cortical
gray matter and hypothalamus, brain calcium was significantly
greater than control values by about 60%. In cortical gray
matter, calcium was 10.1 ± 0.7 mmoles/kg dry weight (control
6.2 ± 0.6 mmoles/kg dry weight, P ( 0.001) while calcium in the
hypothalamus was 14.2 ± 1.9 mmole s/kg dry weight (control =
9.1 ± 1.4 mmoles/kg dry weight, P < 0.01). The water contents
in the aforementioned eight areas of the brain were all normal.
Magnesium content was normal in both gray matter (30.36 ±
1.55; control 30.02 ± 0.84 mmoles/kg dry weight) and white
matter (19.00 ± 0.55; control = 18.83 ± 0.95 mmoles/kg dry
weight).
Effects on the electroencephalogram. The EEG was previ-
ously shown to demonstrate significant abnormalities in every
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Table 4. Electroencephalogram changes in dogs with renal failure
% EEG frequencies
% EEG power
Hz below 5 Hzabove 9 Hz below 7 Hz below 5
Control (N = 9)
57.3 6.8 16.9 3.6
Acute renal failure (3.5 days, N 8)
13.7 4.1 60.4 5.7 27.5 5.0
Chronic renal failure (4 months, N 9)
21.7 2.8 55.5 4.7 30.8 5.3 39 6
quantity evaluated in dogs with ARF [10]. These changes
persisted essentially unaltered after 4 months of CRF (Table 4).
The percentage of EEG frequencies above 9 Hz are normally 57
7%, but they were only 14 4% in dogs with ARF, and 22
3% after 4 months of CRF (both values P < 0.01 versus
control). Similarly, the percentage of EEG frequencies below 7
Hz, which represents largely abnormal activity, was 60 6% in
dogs with ARF and 56 5% after 4 months of CRF, compared
to the control value of 17 4% (P < 0.01 for both values versus
control, Fig. 3).
Peripheral nerve studies
Composition, The effects of renal failure on nerve composi-
tion are shown in Table 5. After 3.5 days of ARF, nerve content
of both sodium and chloride were decreased by 20 to 30% below
control values, while nerve calcium content was 30% below
control (245 17 versus 348 28 mg/kg dry weight, P < 0.01).
The changes in nerve content of sodium, chloride, and calcium
were not affected by parathyroidectomy performed prior to the
onset of ARF (Table 5, group 3). In dogs with CRF for 16 days
to 4 months, nerve calcium content remained significantly
below control, 7.2 0.7 mmoles/kg dry weight at 16 days (P <
0.01 versus control) and 6.6 0.6 mmoles/kg dry weight after 4
months of CRF (P < 0.05 versus control, Table 5). Nerve
chloride content was no longer different from control in dogs
with CRF, while nerve sodium remained slightly but significant-
ly below control after 16 days (P < 0.01) to 4 months (P < 0.01)
of CRF. Nerve content of water, potassium, and magnesium
was unaffected by renal failure (Table 5).
Effects on the MNCV. The motor nerve conduction velocity
(MNCV) was evaluated in normal dogs and those who had renal
failure for periods of 3.5 days to 6 months (Table 5 and Fig. 4).
The control MNCV's in the peroneal and tibia! nerves were 52.9
2.6 M/sec and 57.1 4.4 M/sec, respectively. Over 6 months,
there was no significant change of MNCV in either nerve. Thus,
in contrast to the LEG, where substantial alterations were
present within 3.5 days of renal failure which persisted for at
least 4 months, the MNCV remained normal for at least 6
months of CRF (Fig. 4).
Discussion
These data show that a number of changes in brain composi-
tion occur in CRF. These may relate to the functional changes
which occur, as measured by the EEG. The changes in compo-
sition include an increase in brain osmolarity, of which at least
40% is due to an increase of idiogenic osmoles, and an increase
in the calcium content of specific brain regions: cerebral
cortical gray matter and hypothalamus. Brain water and elec-
trolyte concentration and pHi are normal in CRF, making it
unlikely that either brain edema or intracellular acidosis con-
tributes to the EEG abnormalities seen. Compositional changes
also occurred in peripheral nerve, but were different than those
seen in the brain (calcium, chloride, and sodium content fell)
and no functional changes, as measured by MNCV, were seen.
We found that despite the presence of systemic acidemia
(arterial pH 7.25) for 4 months, intracellular pH (pHi) was
normal in brain, liver, and muscle (Fig. 1). This finding was
striking and is a tribute to the remarkable buffering capacity of
these tissues. We had previously shown that in dogs with ARF,
pHi was normal in skeletal muscle, and brain white and gray
matter [11]. In human subjects with CRF, the pHi has been
found to be normal in whole body [26] and skeletal muscle [27,
28]. Leukocyte pHi in patients with CRF was found to be
alkaline [29]. Thus, alterations in brain pHi probably do not
play a major role in the encephalopathy of renal failure.
In dogs with CRF, brain osmolality is not different from that
of CSF and plasma. The adaptation of brain to extracellular
fluid hyperosmolarity in CRF includes an increase in brain
concentration of urea and idiogenic osmoles. Water content and
ECS remain normal. Therefore, neither cerebral edema nor
cellular volume changes appear to contribute to the altered
CNS function of uremia. Adaptation of brain to a number of
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Gray
10-
Thalamus
Pons
Cerebellum
Fig. 2. The brain calcium content in eight areas
of the brain in dogs with chronic renal failure
(CRF) for 4 months. Brain calcium is significantly
increased in cerebral cortical gray matter and
hypothalamus (* < 0.01; control (U), N = 9;
CRF (c), N = 9).
3.1 1.0 4±1
36 6
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% Frequencies > 9 Hz
C ARF CRF C ARE CRF
Fig. 3. The electroencephalogram (EEG) in control dogs and those with
acute (ARF, N = 8) or chronic (CRF, N = 9) renal failure. After 3.5
days of ARF, there are significant abnormalities in both the percent
EEG frequencies above 9 Hz and the percent EEG power below 5 Hz.
The EEG abnormalities do not improve after 4 months of CRF (* <
0.01).
other endogenous hyperosmolar states is largely through the
addition of idiogenic osmoles [30]. The nature of these idiogenic
osmoles is largely unknown. Because both Na and K may be
bound within the cell (with an osmotic activity coefficient as
low as 0.20), the increase of idiogenic osmoles might represent
simply an increase of osmotic activity of these cations [31]. On
the other hand, there is ample precedent in a number of species
for the generation of low molecular weight compounds within
nerve cells to regulate cell size [30]. This finding of an increase
of idiogenic osmoles in the brain of dogs with CRF is in contrast
to the situation in ARF. With the latter, the brain maintains
osmotic equilibrium with plasma and CSF largely through an
increase of urea and loss of electrolyte, with only a small gain in
idiogenic osmoles [81.
Previous studies, both from our laboratory [9, 10, 121 and
others [5, 19] have shown that calcium content is elevated in
brain cortical gray matter of dogs and humans with ARF. In
dogs with CRF, the measured variation in brain calcium was
small (Fig. 2), while a much larger range was observed in the
patients with CRF [12, 17—20]. This may be because the dogs all
had similar degrees of renal insufficiency, and none were
treated with either phosphate restriction, dialysis, or vitamin D
compounds. The patients represent a heterogeneous group.
There is probably a wide variation in the aforementioned
treatment modalities, any of which might affect brain calcium,
either directly [9] or secondarily by altering plasma PTH levels
[5,9, 12]. We are unaware of studies of calcium content in other
areas of the brain. Data from the present study (Fig. 2) show
that in dogs with CRF brain calcium is elevated only in cortical
gray matter and hypothalamus. The fact that calcium is only
elevated in selected areas of the brain may be one factor to
explain why some studies have revealed such a wide variation
in brain calcium content when separation was not carried out
[20].
Calcium exists in the cell largely sequestered in organelles,
such as mitochondria. Thus, measures of total calcium content
do not necessarily reflect changes in cytosolic calcium [32].
However, the critical importance of calcium in regulating cell
function, and the correlation of changes of total brain calcium
with changes in the EEG suggest this change in brain calcium is
probably related to the pathogenesis of uremic encephalopathy
[10, 12, 32].
The EEG primarily records activity from cerebral cortex and
is markedly abnormal in both patients [12] and dogs [10] with
ARF. In these groups, cerebral cortex gray matter calcium
content is elevated. In our dogs with CRF, calcium content in
cerebral cortical gray matter and hypothalamus remained ele-
vated after 4 months of CRF, and the EEG remained abnormal
(Table 4). In patients or animals with renal failure, hemodialysis
lowers brain calcium toward normal [9, 121 and in patients with
CRF treated with hemodialysis, the EEG approaches a normal
pattern [16, 33, 34]. Thus, there appears to be a relationship
between EEG abnormalities and elevated calcium in some areas
of the brain. We and other investigators [5, 9, 10, 12, 17] have
previously shown that the abnormal EEG findings and in-
creased brain calcium observed in dogs and patients with ARF
are largely PTH dependent. Although not measured in the
present study, our CRF dogs probably had high plasma PTH
levels. Slatopolsky et al [21] have shown that in dogs with a
similar diet and reduction in GFR, plasma PTH levels averaged
ten times the control values. Thus, elevated plasma PTH levels
may be important in the causation of the EEG changes and
brain calcium increment observed in CRF as well.
In nerves from dogs with renal failure of 3.5 days to 4 months
duration, we found decrements in the content of sodium,
chloride, and calcium while that of water, potassium, and
magnesium were unaltered (Table 5), The changes in nerve
electrolyte content during ARF were not modified when dogs
were subjected to prior parathyroidectomy. MNCV was normal
in dogs with ARF (Fig. 4); the result was unaffected by prior
parathyroidectomy (Table 5). Even after 6 months of renal
failure, MNCV remained normal (Fig. 4). Thus, we were unable
to confirm the findings reported by Goldstein, Chui, and
Massry [6] of increased nerve calcium and decreased MNCV in
dogs with ARF. Their use of bilateral nephrectomy to induce
ARF might be expected to result in somewhat different effects
on vitamin D, PTH, and calcium metabolism than the bilateral
ureteral ligation model we used. It is unclear whether these
differences in technique can account for all the observed
discrepancies between our results [6, 35, 361.
The fact that MNCV remains normal after 3.5 days to 6
40
% Power < 5 Hz
*
*
*
0
Chronic renal failure (16 days, N = 10)
204 80 161 7.2 10.2
Chronic renal failure (4 months, N = 10)
241 92 176 6.6 10.1
Chronic renal failure (6 months, N 5)
— 49.5 64.3
—
months of renal failure in dogs is not surprising. Uremic
neuropathy appears to be typical of a metabolic "dying back"
polyneuropathy [37—38] or distal axonopathy. Such axonopath-
ies histologically show primary axonal degeneration and sec-
ondary demyelination. Centrally, the dorsal columns and spino-
cerebellar tracts of the spinal cord are also involved [37].
Uremic neuropathy exhibits all the aforementioned characteris-
tics [39—41] and thus may be considered typical of the group. In
laboratory animals (rats and cats) where toxic neuropathy is
induced, functional changes are generally not observed for
several months after an acute insult [37]. It is thus unlikely that
ARF would result in impaired MNCV, and our studies in both
patients and animals show that MNCV is normal with ARF [121
(Table 4). Although measurement of MNCV has been the
standard for the study of uremic neuropathy, it is not an ideal
measure of this type of neuropathy and is unlikely to be
abnormal without severe, chronic uremia [16].
Thus, our findings are essentially in agreement with most
other studies of nerve function in renal failure. With the recent
tendencies for the earlier institution of dialysis in patients with
CRF, uremic neuropathy appears to be less common. Recently,
Teschan et al [16] found that in patients with CRF who were
treated with dialysis before GFR was below about 12 mI/mm the
MNCV was normal. Several older large series have shown that
among patients with CRF, impairment in MNCV is not general-
ly observed if the GFR is above about 10 mUmin [42—45].
Thus, CRF is associated with changes in brain composition,
though not necessarily in the direction predicted from changes
in plasma. The brain showed remarkable homeostatic ability in
the face of some of the metabolic stresses of uremia. Despite
extracellular fluid acidosis and hyperosmolarity, intracellular
pH and both intra- and extracellular volumes were maintained
normal. The adjustment to hyperosmolarity included a gain in
idiogenic osmoles. Their identity and the role they might play in
uremic encephalopathy remains uncertain. Because both ARF
and CRF are associated with encephalopathy, the difference in
the mode of adaptation to extracellular hyperosmolarity in
these two models of uremia lessens the likelihood that idiogenic
osmoles are involved in the causation of uremic encephalop-
athy. In contrast, increases in the calcium content of certain
brain regions have been consistent findings in both ARF and
CRF and correlate best to date with uremic encephalopathy, as
measured by the EEG. Although the mineral and electrolyte
content of nerve was also affected by renal failure, the changes
seen were dissimilar to those occurring in the brain and did not
lead to functional abnormalities, as assessed by the MNCV. We
are unable to differentiate the role of uremia, per se, in
producing the observed effects from possible alterations in
nutritional status which may also have occurred.
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